CA scope of practice bill moves to Appropriations Committee

Article

The unanimously passed the Senate Business, Professions, and Economic Development Committee.

Sacramento, CA-California’s SB 492 last week unanimously passed the Senate Business, Professions, and Economic Development Committee. This bill, along with companion bills SB 491 and SB 493, next move to the Appropriations Committee.

SB 491-493 proposes to expand the scope of practice for non-physicians in anticipation of a healthcare provider shortage after the Affordable Care Act provides healthcare coverage to millions of uninsured Americans. These bills would designate optometrists as primary-care providers to diagnose and treat patients with chronic diseases, such as diabetes, allow nurse practitioners to establish independent practices, and designate pharmacists as primary-care providers. The bills were proposed by California Senator Ed Hernandez, OD.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Patricia Buehler, MD, MPH, at ASCRS 2025
Brett Bielory, MD, at ASCRS 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
Dr Ashley Wallace Tucker speaks on the Myopia Management Navigator.
Matt Jones, OD; Matt Burns; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
© 2025 MJH Life Sciences

All rights reserved.